Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

Retrophin (NASDAQ:TVTX) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Retrophin will report an earnings per share (EPS) of $-0.85.

Benzinga

4 Analysts Have This to Say About Incyte

Analysts have provided the following ratings for Incyte (NASDAQ:INCY) within the last quarter:

Benzinga

Atara Biotherapeutics Earnings Preview

Atara Biotherapeutics (NASDAQ:ATRA) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Atara Biotherapeutics will report an earnings per share (EPS) of $-0.98.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Here's How Much You Would Have Made Owning Carlyle Group Stock In The Last 5 Years

Carlyle Group (NASDAQ:CG) has outperformed the market over the past 5 years by 5.36% on an annualized basis producing an average annual return of 17.25%. Currently, Carlyle Group has a market capitalization of $14.31 billion.

Benzinga

Earnings Outlook For Curis

Curis (NASDAQ:CRIS) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Curis will report an earnings per share (EPS) of $-0.16.

Benzinga

A Preview Of Prothena Corp's Earnings

Prothena Corp (NASDAQ:PRTA) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Prothena Corp will report an earnings per share (EPS) of $-0.68.

Benzinga

Analyst Ratings for Veracyte

Within the last quarter, Veracyte (NASDAQ:VCYT) has observed the following analyst ratings:

Benzinga

Read news from The Economist, FT, and more,
with one subscription

A Preview Of INmune Bio's Earnings

INmune Bio (NASDAQ:INMB) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that INmune Bio will report an earnings per share (EPS) of $-0.64.

Benzinga

What's Going On With Plug Power Shares Today?

Shares of several companies in the broader industrials sector, including Plug Power Inc (NASDAQ: PLUG), are trading higher amid overall market strength after the Federal Reserve announced it would raise the key interest rate by 50 basis points.

Benzinga

Lyft Analysts React To Q2 Guidance Miss, Heavy Investments In Lagging Driver Recovery

LYFT Inc (NASDAQ: LYFT) shares plummeted 32% on Wednesday after the company issued second-quarter guidance that came up well short of market expectations.

Benzinga

What's Going On With Apple Shares Today?

Shares of several companies in the broader tech sector, including Apple Inc (NASDAQ: AAPL), are trading higher amid overall market strength after the Federal Reserve announced it would raise the key interest rate by 50 basis points.

Benzinga

Oatly Group Reports Mixed Q1 Earnings; Reiterates FY22 Outlook

Oatly Group AB (NASDAQ:OTLY) reported first-quarter FY22 sales growth of 18.6% year-on-year to $166.19 million, beating the consensus of $161.78 million. Revenue in the Americas jumped 40.3% Y/Y to $47 million, EMEA rose 10.9% to $90.5 million, and Asia grew 15.3% to $28.7 million. Gross margin contracted by 2,040 basis points to 9.5%,…

Benzinga

Mid-Afternoon Market Update: Crude Oil Jumps 5%; Fed Boosts Interest Rates By 0.5%

U.S. stocks traded mixed toward the end of trading, after the Federal Reserve announced its policy decision.

Benzinga

ODP Q1 Earnings Beat Estimates Despite Fewer Retail Stores

ODP Corp (NASDAQ:ODP) reported a first-quarter FY22 sales of $2.18 billion, flat Y/Y, beating the consensus of $2.13 billion. Business Solutions Division sales climbed 9% Y/Y, while Retail division sales decreased 9%. Adjusted EPS of $1.27 beat the analyst consensus of $0.79. Gross profit declined 2.2% Y/Y to $484 million with a margin…

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

A Preview Of Oncolytics Biotech's Earnings

Oncolytics Biotech (NASDAQ:ONCY) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Oncolytics Biotech will report an earnings per share (EPS) of $-0.11.

Benzinga

Preview: Corcept Therapeutics's Earnings

Corcept Therapeutics (NASDAQ:CORT) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Corcept Therapeutics will report an earnings per share (EPS) of $0.24.

Benzinga

A Preview Of Mirum Pharmaceuticals's Earnings

Mirum Pharmaceuticals (NASDAQ:MIRM) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Mirum Pharmaceuticals will report an earnings per share (EPS) of $-1.34.

Benzinga

Earnings Outlook For Selecta Biosciences

Selecta Biosciences (NASDAQ:SELB) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Selecta Biosciences will report an earnings per share (EPS) of $-0.11.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Akoya Biosciences Earnings Preview

Akoya Biosciences (NASDAQ:AKYA) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Akoya Biosciences will report an earnings per share (EPS) of $-0.39.

Benzinga

Check Out What Whales Are Doing With BYND

Someone with a lot of money to spend has taken a bearish stance on Beyond Meat (NASDAQ:BYND). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Twist Bioscience's Earnings: A Preview

Twist Bioscience (NASDAQ:TWST) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Twist Bioscience will report an earnings per share (EPS) of $-1.28.

Benzinga

What 4 Analyst Ratings Have To Say About Paramount Global

Analysts have provided the following ratings for Paramount Global (NASDAQ:PARA) within the last quarter:

Benzinga

AMD, Micron Or Nvidia: Which Chip Stock Did This Investor Just Dump And Why?

Steve Weiss cut Micron Technology Inc (NASDAQ: MU) from his portfolio on Wednesday, citing concerns that he suggested could be plaguing the entire semiconductor industry.

Benzinga

Earnings Outlook For Franchise Group

Franchise Group (NASDAQ:FRG) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Franchise Group will report an earnings per share (EPS) of $1.09.

Benzinga

This Is What Whales Are Betting On Fortinet

Someone with a lot of money to spend has taken a bearish stance on Fortinet (NASDAQ:FTNT). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

1 … 632 633 634 635

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.